Timber Creek Capital Management LLC Sells 47,835 Shares of Koninklijke Philips (NYSE:PHG)

Timber Creek Capital Management LLC lowered its holdings in Koninklijke Philips (NYSE:PHG - Free Report) by 73.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 17,173 shares of the technology company's stock after selling 47,835 shares during the quarter. Timber Creek Capital Management LLC's holdings in Koninklijke Philips were worth $435,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the business. FMR LLC lifted its holdings in Koninklijke Philips by 0.6% in the 3rd quarter. FMR LLC now owns 6,138,708 shares of the technology company's stock worth $200,859,000 after buying an additional 35,935 shares during the period. Bank of Montreal Can lifted its holdings in Koninklijke Philips by 2,883.5% in the 3rd quarter. Bank of Montreal Can now owns 982,199 shares of the technology company's stock worth $32,157,000 after buying an additional 949,278 shares during the period. IHT Wealth Management LLC purchased a new stake in Koninklijke Philips in the 3rd quarter worth approximately $19,593,000. Bar Harbor Wealth Management lifted its holdings in Koninklijke Philips by 2.1% in the 4th quarter. Bar Harbor Wealth Management now owns 308,157 shares of the technology company's stock worth $7,803,000 after buying an additional 6,281 shares during the period. Finally, JPMorgan Chase & Co. lifted its stake in shares of Koninklijke Philips by 315.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 245,729 shares of the technology company's stock valued at $8,040,000 after purchasing an additional 186,520 shares during the period. Hedge funds and other institutional investors own 13.67% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on PHG shares. Jefferies Financial Group upgraded Koninklijke Philips from an "underperform" rating to a "hold" rating in a research note on Tuesday, October 29th. UBS Group upgraded Koninklijke Philips from a "neutral" rating to a "buy" rating in a research note on Thursday. Finally, StockNews.com upgraded Koninklijke Philips from a "hold" rating to a "buy" rating in a research note on Thursday. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy".

Koninklijke Philips Stock Up 2.0 %

NYSE:PHG traded up $0.50 during trading hours on Friday, reaching $25.53. 2,295,393 shares of the company traded hands, compared to its average volume of 710,086. The business's 50-day moving average price is $26.25 and its two-hundred day moving average price is $28.14. The stock has a market capitalization of $24.00 billion, a P/E ratio of -30.40, a P/E/G ratio of 0.82 and a beta of 0.77. Koninklijke Philips has a 1 year low of $19.75 and a 1 year high of $32.91. The company has a current ratio of 1.23, a quick ratio of 0.74 and a debt-to-equity ratio of 0.59.

Koninklijke Philips (NYSE:PHG - Get Free Report) last announced its quarterly earnings data on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.55 by ($0.01). The company had revenue of $5.38 billion for the quarter, compared to analysts' expectations of $5.10 billion. Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. Analysts predict that Koninklijke Philips will post 1.63 earnings per share for the current year.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.